Results 61 to 70 of about 25,773 (228)

Longitudinal changes in virological, biochemical and serological responses in subsequent months of ETV therapy in HBeAg(+) and HBeAg(-) patients at baseline.

open access: yes, 2016
Frequencies of HBV DNA
Paweł Rajewski (3185898)   +6 more
core   +1 more source

Manifestations of perihepatic lymph nodes in acute flare of chronic hepatitis B: association with HBeAg status and with HBeAg seroconversion. [PDF]

open access: yesPLoS ONE, 2015
UNLABELLED:It has been observed that enlargement of perihepatic lymph nodes may be seen in patients with chronic hepatitis B, particularly during acute flares of CHB.
Yen-Ling Ko   +9 more
doaj   +1 more source

On‐Treatment Reassessment of Type IV Collagen 7S and M2BPGi‐Qt Improves Long‐Term Hepatocellular Carcinoma Risk Stratification in Chronic Hepatitis B

open access: yesHepatology Research, EarlyView.
One‐year reassessment of type IV collagen 7S, supported by quantitative M2BPGi‐Qt assessment, helped refine long‐term hepatocellular carcinoma risk stratification in patients with chronic hepatitis B receiving nucleos(t)ide analogue therapy. On‐treatment 4COL7S emerged as a novel marker of residual fibrosis‐related HCC risk.
Kazumi Yamasaki   +9 more
wiley   +1 more source

Association between HBV genotype, HBeAg status and viral load.

open access: yes, 2015
GT, genotype; HBV DNA, hepatitis B viral DNA; HBeAg, hepatitis B e antigenAssociation between HBV genotype, HBeAg status and viral load.
Leland Yee (706287)   +7 more
core   +1 more source

Hepatitis D virus infection in persons with HIV and hepatitis B virus across Europe: A cross‐sectional analysis of the HDV‐Europe cohort

open access: yesHIV Medicine, EarlyView.
Abstract Introduction Infection with hepatitis D virus (HDV) is known to accelerate the progression of liver disease and is associated with mortality in individuals with HIV and hepatitis B virus (HBV). However, little is known about current HDV epidemiology, including HDV‐testing practices and prevalence, in this population in Europe.
Anders Boyd   +18 more
wiley   +1 more source

Comparison between HBeAg positive and HBeAg negative subjects with respect to varying HBV DNA levels.

open access: yes, 2013
Major proportion of HBeAg positive subjects were associated with higher HBV DNA levels compared to HBeAg negative subjects.
Debraj Saha (452305)   +10 more
core   +1 more source

Impact of HBeAg on Hepatocellular Carcinoma Risk During Oral Antiviral Treatment in Patients With Chronic Hepatitis B

open access: yes, 2022
Background & Aims: Antiviral treatment from hepatitis B envelope antigen (HBeAg)-positive status may attenuate the integration of hepatitis B virus DNA into the host genome causing hepatocellular carcinoma (HCC).
Lee HA   +34 more
core   +2 more sources

Hepatitis B in Organ Transplantation—Current Evidence and Clinical Gaps

open access: yesTransplant Infectious Disease, EarlyView.
ABSTRACT Over the past several decades there have been significant advances in nucleos(t)ide analogue (NA) antiviral therapy for hepatitis B virus (HBV) and global expansion of primary prevention through immunization. Despite this, HBV remains a leading cause of chronic liver disease globally, affecting over 250 million people.
Oscar A. Fernandez‐Garcia   +3 more
wiley   +1 more source

Liver Histopathological Features Influencing HBeAg Seroconversion in Patients with HBeAg-positive Chronic Hepatitis B Treated with Pegylated Interferon α

open access: yes, 2014
Objective To investigate the efficiency of pegylated interferon α therapy for patients with HBeAg-positive chronic hepatitis B (CHB) and explore whether liver histopathological features and other factors might influence HBeAg seroconversion.
Cheng-liang Zhu   +4 more
core   +1 more source

Prevalence and clinical significance of HBeAg-positive chronic hepatitis B patients with and without anti-HBe antibody

open access: yesVirulence
The clinical significance of the coexistence of hepatitis B e antigen (HBeAg) and antibodies against HBeAg (anti-HBe) in patients with chronic hepatitis B (CHB) remains unclear.
Ruifei Xue   +14 more
doaj   +1 more source

Home - About - Disclaimer - Privacy